- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sitagliptin
Total 819 results
-
Peking University People's HospitalRecruitingBlood Coagulation Disorders | Thrombocytopenia | Immune Thrombocytopenia | Physiological Effects of DrugsChina
-
SK Chemicals Co., Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Kansai Electric Power HospitalSaiseikai Noe Hospital OsakaCompletedDiabetes Mellitus, Type 2Japan
-
Woman'sMerck Sharp & Dohme LLCCompletedDisorder of Glucose RegulationUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Spain, United Kingdom, United States, France
-
Dokkyo Medical UniversityMerck Sharp & Dohme LLCUnknown
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Netherlands, Portugal, Spain, Turkey, India, Austria, Egypt, Greece, Israel, Mexico, United Kingdom, Korea, Republic of, Hong Kong, Colombia, Lebanon
-
Ludwig-Maximilians - University of MunichMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusGermany
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
University of VermontCompletedImpaired Glucose Tolerance | Pre-diabetes | Impaired Fasting GlucoseUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)
-
Dong Wha Pharmaceutical Co. Ltd.CompletedA Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersHealthy SubjectsKorea, Republic of
-
Chinese PLA General HospitalUnknownAtherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
-
University of DundeeCompletedDiabetes Mellitus, Type 2United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompletedType 2 Diabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Bulgaria, Czech Republic, Hungary, Poland
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
Boehringer IngelheimCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
University Hospital, Gentofte, CopenhagenCompletedType2 DiabetesDenmark
-
Novartis PharmaceuticalsCompletedAcromegaly | Cushing's DiseaseUnited States, Turkey, Belgium, Thailand, Germany, Denmark, Russian Federation, Peru, China, Brazil, India, Poland
-
Chong Kun Dang PharmaceuticalCompletedDiabetes Mellitus Type 2Korea, Republic of
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
Wuhan General Hospital of Guangzhou Military CommandCompletedCoronary Artery Disease | Newly Diagnosed Type 2 DiabetesChina
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Ludwig-Maximilians - University of MunichTerminated
-
Galenicum HealthCompletedType 2 Diabetes | BioequivalenceCanada
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceCanada
-
Merck Sharp & Dohme LLCCompleted
-
Daiichi Sankyo Co., Ltd.CompletedType2 Diabetes MellitusJapan
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
GlaxoSmithKlineCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Austria, Croatia, Czech Republic, Estonia, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Norway, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Ukraine
-
Jothydev's Diabetes and Research CentreCompletedDiabetes Mellitus, Type 2India
-
University of British ColumbiaTerminated
-
VIVUS LLCCompleted
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingOvarian Cancer | Fallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France